Elacridar (C007B-144958)

Catalog No.: C007B-144958
Manufacturer No.: E126576-100mg
Manufacturer Name: Aladdin Scientific
Quantity: 1
Unit of Measure: EA

Elacridar (GF120918: GW0918) is a P-glycoprotein inhibitor and has been used both in vitro and in vivo as a tool inhibitor of P-glycoprotein (Pgp) to investigate the role of transporters in the disposition of various test molecules. A prototypical

Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account. Contact Us

Description
Specifications

Elacridar (GF120918; GW0918) is a P-glycoprotein inhibitor and has been used both in vitro and in vivo as a tool inhibitor of P-glycoprotein (Pgp) to investigate the role of transporters in the disposition of various test molecules. A prototypical BCRP (ABCG2) inhibitor.

Specifications and Purity: ≥98%

MDL Number: MFCD00912604

Molecular Formula: C34H33N3O5

Molecular Weight: 563.64

PubChem CID: 119373

Isomeric SMILES: COC1=CC=CC2=C1NC3=C(C2=O)C=CC=C3C(=O)NC4=CC=C(C=C4)CCN5CCC6=CC(=C(C=C6C5)OC)OC

Related Documents: https://aladdin-for-icloud-store.oss-cn-hangzhou.aliyuncs.com/aladdinsci/pdp/sds/1/E126576-SCI_25535ab04d4f4a4f00fab7f3f052fb5d.pdf

UPC:: 41114502
Condition:: New
HazmatClass:: No
WeightUOM:: LB
MPN:: E126576-100mg
CAS:: 143664-11-3
Product Size:: 100mg

Cenmed Satisfaction Guarantee

At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.

"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was presently surprised by their product offering."